A functional intronic variant in the tyrosine hydroxylase (TH) gene confers risk of essential hypertension in the Northern Chinese Han population

Clinical Science

Volumn 115, Issue 5-6, 2008, Pages 151-158

  Wang, Laiyuan ^a,b   Li, Biao ^c   Lu, Xiangfeng ^a   Zhao, Qi ^a   Li, Yun ^a   Ge, Dongliang ^a   Li, Hongfan ^a   Zhang, Penghua ^a   Chen, Shufeng ^a   Chen, Runsheng ^c   Qiang, Boqin ^b   Gu, Dongfeng ^a,b  

^a FUWAI HOSPITAL   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Association study; Essential hypertension; Haplotype; Transcriptional repressor; Tyrosine hydroxylase

Indexed keywords

CATECHOLAMINE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR YY1; TYROSINE 3 MONOOXYGENASE;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CATECHOLAMINE SYNTHESIS; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN; CELL CULTURE; CLINICAL TRIAL; ETHNOLOGY; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROTEIN BINDING;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; INTRONS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; TUMOR CELLS, CULTURED; TYROSINE 3-MONOOXYGENASE;

EID: 49649086769     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070335     Document Type: Article

References (42)

1. Chobanian, A. V., Bakris, G. L., Black, H. R. et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, J. Am. Med. Assoc. 289, 2560-2572
2. Petersen, S., Rayner, M. and Press, V. (2000) Coronary heart disease statistics, British Heart Foundation Statistics Database, http://www.bhf.org.uk
3. Gu, D., Reynolds, K., Wu, X. et al. (2002) Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 40, 920-927
4. Rice, T., Rankinen, T., Province, M. A. et al. (2000) Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation 102, 1956-1963
5. Harrap, S. B. (1994) Hypertension: genes versus environment. Lancet 344, 169-171
6. Meloni, R., Laurent, C., Campion, D. et al. (1995) A rare allele of a microsatellite located in the tyrosine hydroxylase gene found in schizophrenic patients. C. R. Acad. Sci. Ser. III 318, 803-809
7. Nagatsu, T., Levitt, M. and Udenfriend, S. (1964) Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues. Biochem. Biophys. Res. Commun. 14, 543-549
8. Goldstein, D. S. (1983) Plasma catecholamines and essential hypertension. An analytical review. Hypertension 5, 86-99
9. Sharma, P., Hingorani, A., Jia, H. et al. (1998) Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension. Hypertension 32, 676-682
10. O'Malley, K. L., Anhalt, M. J., Martin, B. M., Kelsoe, J. R., Winfield, S. L. and Ginns, E. I. (1987) Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5′ alternative splice sites responsible for multiple mRNAs. Biochemistry 26, 6910-6914
11. Furlong, R. A., Rubinsztein, J. S., Ho, L. et al. (1999) Analysis and metaanalysis of two polymorphisms within the tyrosine hydroxylase gene in bipolar and unipolar affective disorders. Am. J. Med. Genet. 88, 88-94
12. Kawada, Y., Hattori, M., Fukuda, R., Arai, H., Inoue, R. and Nanko, S. (1995) No evidence of linkage or association between tyrosine hydroxylase gene and affective disorder. J. Affect. Disord. 34, 89-94
13. Souery, D., Lipp, O., Rivelli, S. K. et al. (1999) Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: a multicenter association study. Am. J. Med. Genet. 88, 527-532
14. Chao, H. M. and Richardson, M. A. (2002) Aromatic amino acid hydroxylase genes and schizophrenia. Am. J. Med. Genet. 114, 626-630
15. Kunugi, H., Kawada, Y., Hattori, M., Ueki, A., Otsuka, M. and Nanko, S. (1998) Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson's disease. Am. J. Med. Genet. 81, 131-133
16. Pae, C. U., Kim, J. J., Serretti, A. et al. (2003) VNTR polymorphism of tyrosine hydroxylase gene and schizophrenia in the Korean population. Neuropsychobiology 47, 131-136
17. Kurumaji, A., Kuroda, T., Yamada, K., Yoshikawa, T. and Toru, M. (2001) An association of the polymorphic repeat of tetranucleotide (TCAT) in the first intron of the human tyrosine hydroxylase gene with schizophrenia in a Japanese sample. J. Neural Transm. 108, 489-495
18. Anney, R. J., Olsson, C. A., Lotfi-Miri, M., Patton, G. C. and Williamson, R. (2004) Nicotine dependence in a prospective population-based study of adolescents: the protective role of a functional tyrosine hydroxylase polymorphism. Pharmacogenetics 14, 73-81
19. Olsson, C., Anney, R., Forrest, S. et al. (2004) Association between dependent smoking and a polymorphism in the tyrosine hydroxylase gene in a prospective population-based study of adolescent health. Behav. Genet. 34, 85-91
20. Rodriguez, S., Huang, S., Chen, X. H. et al. (2006) A study of TH01 and IGF2-INS-TH haplotypes in relation to smoking initiation in three independent surveys. Pharmacogenet. Genomics 16, 15-23
21. Zhang, L., Rao, F., Wessel, J. et al. (2004) Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol. Genomics 19, 277-291
22. Klintschar, M., Immel, U. D., Stiller, D. and Kleiber, M. (2005) TH01, a tetrameric short tandem repeat locus in the tyrosine hydroxylase gene: association with myocardial hypertrophy and death from myocardial infarction? Dis. Markers 21, 9-13
23. Gu, D., Su, S., Ge, D. et al. (2006) Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 47, 1147-1154
24. Levy, D., DeStefano, A. L., Larson, M. G. et al. (2000) Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension 36, 477-483
25. Abecasis, G. R. and Cookson, W. O. (2000) GOLD: graphical overview of linkage disequilibrium. Bioinformatics 16, 182-183
26. Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M. and Poland, G. A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70, 425-434
27. Akey, J., Jin, L. and Xiong, M. (2001) Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur. J. Hum. Genet. 9, 291-300
28. Johnson, G. C., Esposito, L., Barratt, B. J. et al. (2001) Haplotype tagging for the identification of common disease genes. Nat. Genet. 29, 233-237
29. Rioux, J. D., Daly, M. J., Silverberg, M. S. et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29, 223-228
30. Kobayashi, K. and Nagatsu, T. (2005) Molecular genetics of tyrosine 3-monooxygenase and inherited diseases. Biochem. Biophys. Res. Commun. 338, 267-270
31. Meng, F., Zolova, O., Kokorina, N. A., Dobretsova, A. and Wight, P. A. (2005) Characterization of an intronic enhancer that regulates myelin proteolipid protein (Plp) gene expression in oligodendrocytes. J. Neurosci. Res. 82, 346-356
32. Stemmler, M. P., Hecht, A. and Kemler, R. (2005) E-cadherin intron 2 contains as-regulatory elements essential for gene expression. Development 132, 965-976
33. Shirai, T., Miyagi, S., Horiuchi, D. et al. (2005) Identification of an enhancer that controls up-regulation of fibronectin during differentiation of embryonic stem cells into extraembryonic endoderm. J. Biol. Chem. 280, 7244-7252
34. Palii, S. S., Chen, H. and Kilberg, M. S. (2004) Transcriptional control of the human sodium-coupled neutral amino acid transporter system A gene by amino acid availability is mediated by an intronic element. J. Biol. Chem. 279, 3463-3471
35. Hwang, E. S., Choi, A. and Ho, I. C. (2002) Transcriptional regulation of GATA-3 by an intronic regulatory region and fetal liver zinc finger protein 1. J. Immunol. 169, 248-253
36. Gregori, C., Porteu, A., Lopez, S., Kahn, A. and Pichard, A. L. (1998) Characterization of the aldolase B intronic enhancer. J. Biol. Chem. 273, 25237-25243
37. Kawaida, R., Yamada, R., Kobayashi, K. et al. (2005) CUL1, a component of E3 ubiquitin ligase, alters lymphocyte signal transduction with possible effect on rheumatoid arthritis. Genes Immun. 6, 194-202
38. Ozaki, K., Ohnishi, Y., Iida, A. et al. (2002) Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32, 650-654
39. Ozaki, K., Inoue, K., Sato, H. et al. (2004) Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 429, 72-75
40. Meloni, R., Albanese, V., Ravassard, P., Treilhou, F. and Mallet, J. (1998) A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Hum. Mol. Genet. 7, 423-428
41. Albanese, V., Biguet, N. F., Kiefer, H., Bayard, E., Mallet, J. and Meloni, R. (2001) Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum. Mol. Genet. 10, 1785-1792
42. Rao, F., Zhang, L., Wessel, J. et al. (2007) Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 116, 993-1006